CID is 3034010
synonyms found at PubChem are:
orlistat, 96829-58-2, Tetrahydrolipstatin, Xenical, Alli, Orlipastat, (-)-Tetrahydrolipstatin, Orlipastatum, Orlipastatum [INN-Latin], THLP, tetrahydrolipastatin, Orlistat [USAN:INN], Ro-18-0647, Xenical (TN), UNII-95M8R751W8, C29H53NO5, Ro 18-0647/002, (2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate, N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester, Orlistat (Alli, Xenical), MLS002207022, CHEMBL175247, [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate, N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone, 95M8R751W8, KS-1183, SMR000466339, R-212, Ro 18-0647/008, L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-, (S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl formyl-L-leucinate, L-Leucine,N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, [(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate, L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, SR-01000759417, orlistatum, Orlistat [USAN:INN:BAN], HSDB 7556, N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester, zlchem 13, Alli (TN), AC1MHWQP, PubChem18271, Roche brand of orlistat, Orlistat (USAN/INN), Orlistat,Tetrahydolipstat, (-)-tetrahydrolipostatin, D0T9TJ, Orlistat, >=98%, solid, SCHEMBL16408, Orlistat (JAN/USAN/INN), MLS000759448, MLS001423955, BIDD:GT0853, GTPL5277, LEU002, DTXSID8023395, BDBM24567, CHEBI:94686, AOB6737, GlaxoSmithKline brand of orlistat, ZLA0015, AHLBNYSZXLDEJQ-FWEHEUNISA-N, L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester, MolPort-005-938-035, HMS2051I08, HY-B0218, THL, ZINC8214635, Hoffmann-La Roche brand of orlistat, MFCD05662360, s1629, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate, AKOS015894875, BCP9001031, CCG-100851, CS-2165, DB01083, NC00101, RL06088, NCGC00165856-01, NCGC00165856-02, AN-15658, BC214880, CPD000466339, SAM001246637, SC-16265, BCP0726000044, Tetrahydrolipstatin|||Ro 18-0647/002, AB1009256, LS-178328, Ro-180647002, Alli, Xenical, Tetrahydrolipstatin, Orlistat, FT-0082584, FT-0601570, O0381, Ro-180647-002, ST24048848, Ro-18-0647/002, D04028, J90006, AB00639987-09, AB00639987_10, 829O582, Q-201519, SR-01000759417-5, SR-01000759417-7, Z2379810072, Orlistat, United States Pharmacopeia (USP) Reference Standard, Orlistat, Pharmaceutical Secondary Standard; Certified Reference Material, (2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate, 2-formamido-3-[(3-hexyl-4-oxo-oxetan-2-yl)methyl]-2-isobutyl-tetradecanoate, N-formyl-L-leucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester, N-formyl-L-leucine-(S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-dodecyl ester, (-)-Tetrahydrolipstatin; N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl] dodecyl ester; Ro-18-0647, (2S)-2-formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester, (S)-((S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate, 111397-16-1